Stay updated on Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.

Latest updates to the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding NYX-783 for PTSD and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference10%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.